Site FR33005

Toulouse

1 studies enrolling now · 1 studies all time

What they study most

Anaplastic Lymphoma Kinase (ALK) Positive, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) — Recruiting now